Sitzung 4
Next Generation ADO (NGA): Perspektiven des wissenschaftlichen Nachwuchses

Programme

• 10:45 – 11:05 17 Min. 3 Min.

  • Vortrag

  New horizons in cancer research: insights and perspectives of single-cell RNA-sequencing

  • Prof. Emmanuel Saliba (Würzburg)

  
• 11:05 – 11:15 7 Min. 3 Min.

  • Freier Vortrag
  • FV08

  Enhanced survival and progression results in advanced melanoma patients undergoing targeted therapy alongside antithrombotic treatment – insights from a multicenter study involving 1305 patients from the prospective Skin Cancer Registry ADOReg

  • Noah Zimmermann (Hamburg)
• 11:15 – 11:25 7 Min. 3 Min.

  • Freier Vortrag
  • FV09

  Correlation of laboratory parameters at the start of adjuvant treatment of stage III melanoma patients with clinical outcome: A multicentre real world study

  • Dr. Georg Christian Lodde (Essen)
• 11:25 – 11:35 7 Min. 3 Min.

  • Freier Vortrag
  • FV10

  Low skeletal muscle mass predicts melanoma-specific survival in melanoma patients treated with adjuvant immune checkpoint blockade

  • Dr. Miriam Mengoni (Magdeburg)
• 11:35 – 11:45 7 Min. 3 Min.

  • Freier Vortrag
  • FV11

  Translational data from a multicenter phase II study on dimethyl fumarate treatment in relapsed and refractory cutaneous T cell lymphoma

  • Dr. Susanne Melchers (Mannheim)
• 11:45 – 11:55 7 Min. 3 Min.

  • Freier Vortrag
  • FV12

  Role of ARHGAP29 in malignant melanoma

  • Dr. rer. nat. Nicole Rachinger (Erlangen)
• 11:55 – 12:05 7 Min. 3 Min.

  • Freier Vortrag

  The transcription factor MAFF in BRAFV600E-mutated malignant melanoma

  • Till Gallasch (Würzburg)
• 12:05 – 12:15 7 Min. 3 Min.

  • Freier Vortrag

  Spatial dissection of the tumor microenvironment identifies unique tissue motifs predicting response to checkpoint inhibitor therapy in advanced Merkel cell carcinoma

  • Maximilian Haist (Mainz)